Research Paper Volume 15, Issue 14 pp 7056—7083
Identifying the oncogenic roles of FAP in human cancers based on systematic analysis
Figure 13. Immunotherapy prediction analysis and drug sensitivity analysis. (A) Kaplan-Meier analysis of the association between FAP expression and OS in the IMvigor210 cohort. (B) The proportion of BLCA patients who responded to anti-PD-L1 therapy in the groups with the low and high FAP expression. (C) Kaplan-Meier analysis of the association between FAP expression and OS in the GSE78220 cohort. (D) The proportion of SKCM patients who responded to anti-PD1 therapy in the groups with the low and high FAP expression. (E) An illustration of the relationship between FAP expression and expected medication response. (F) The mRNA expression levels of FAP in different cell lines (HK-2, 769-P, ACHN) were measured by RT-qPCR.